Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ): Price and Financial Metrics


Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ)

Today's Latest Price: $147.72 USD

2.25 (-1.50%)

Updated Oct 19 5:20pm

Add JAZZ to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 384 in Biotech

See all "A" rated Strong Buy stocks

JAZZ Stock Summary

  • JAZZ has a higher market value than 82.86% of US stocks; more precisely, its current market capitalization is $8,317,130,891.
  • With a price/earnings ratio of 62.42, Jazz Pharmaceuticals plc P/E ratio is greater than that of about 85.55% of stocks in our set with positive earnings.
  • In terms of volatility of its share price, JAZZ is more volatile than just 21.71% of stocks we're observing.
  • Stocks that are quantitatively similar to JAZZ, based on their financial statements, market capitalization, and price volatility, are FSLR, COHR, ELAN, LFUS, and LIVN.
  • Visit JAZZ's SEC page to see the company's official filings. To visit the company's web site, go to www.jazzpharma.com.

JAZZ Stock Price Chart Interactive Chart >

Price chart for JAZZ

JAZZ Price/Volume Stats

Current price $147.72 52-week high $156.26
Prev. close $149.97 52-week low $86.88
Day low $147.35 Volume 480,926
Day high $150.98 Avg. volume 699,282
50-day MA $137.16 Dividend yield N/A
200-day MA $122.78 Market Cap 8.19B

Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ) Company Bio


Jazz Pharmaceuticals is an international biopharmaceutical company with a diverse portfolio of products and/or product candidates with a focus in the areas of sleep and hematology/oncology. The company was founded in 2003 and is based in Dublin, Ireland.


JAZZ Latest News Stream


Event/Time News Detail
Loading, please wait...

JAZZ Latest Social Stream


Loading social stream, please wait...

View Full JAZZ Social Stream

Latest JAZZ News From Around the Web

Below are the latest news stories about Jazz Pharmaceuticals plc that investors may wish to consider to help them evaluate JAZZ as an investment opportunity.

Is Jazz Pharmaceuticals a Top Stock to Buy Now?

Despite a poor performance of late, this biotech stock could bounce back.

The Motley Fool | September 23, 2020

Jazz Pharmaceuticals Launches Initiative to Help Educate People Living with Rare Form of Leukemia

DUBLIN, Sept. 17, 2020 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the launch of Find the Right Fit (FindTheRightFit-sAML.com), a U.S. patient education program developed in consultation with the Myelodysplastic Syndromes (MDS) Foundation, Inc. and the Cancer…

PR Newswire | September 17, 2020

Redx Pharma inks research pact with Jazz Pharma for cancer

Jazz Pharmaceuticals (JAZZ) has signed a research collaboration agreement with Redx Pharma to discover and develop drug candidates for two cancer targets in the Ras/Raf/MAP kinase ((MAPK)) pathway.Under the terms of the agreement, Jazz will make an upfront payment to Redx of $10M, followed by another $10M in year two,...

Seeking Alpha | September 9, 2020

Jazz Pharmaceuticals Announces New Research Collaboration with Redx Pharma to Discover and Develop Two Targeted Cancer Therapies

DUBLIN, Sept. 9, 2020 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company has signed a new research collaboration agreement with Redx Pharma plc (AIM: REDX) to discover and develop drug candidates for two cancer targets in the Ras/Raf/MAP kinase (MAPK)…

PR Newswire | September 9, 2020

Jazz Pharmaceuticals Announces Participation at Three Upcoming Virtual Investor Conferences

DUBLIN, Sept. 8, 2020 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will webcast its corporate presentations at the following virtual investor conferences: Morgan Stanley Global Healthcare Conference on Tuesday, September 15, 2020 at 2:45 p.m….

PR Newswire | September 8, 2020

Read More 'JAZZ' Stories Here

JAZZ Price Returns

1-mo 4.10%
3-mo 39.99%
6-mo 44.20%
1-year 23.46%
3-year 2.55%
5-year 21.14%
YTD -1.05%
2019 20.43%
2018 -7.94%
2017 23.50%
2016 -22.43%
2015 -14.15%

Continue Researching JAZZ

Here are a few links from around the web to help you further your research on Jazz Pharmaceuticals plc's stock as an investment opportunity:

Jazz Pharmaceuticals plc (JAZZ) Stock Price | Nasdaq
Jazz Pharmaceuticals plc (JAZZ) Stock Quote, History and News - Yahoo Finance
Jazz Pharmaceuticals plc (JAZZ) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7065 seconds.